Medtronic and the Medtronic Foundation Expand COVID-19 Support to More Than $46 Million USD

- With the pandemic surging across the globe and food insecurity on the rise, Medtronic and the Medtronic Foundation today announced an additional $3.8 million commitment to provide healthcare worker support and protection, mental health support, operational support and food assistance to organizations and communities in need. This new commitment is in addition to charitable contributions made earlier this year and brings the total of the company's COVID-19 relief efforts to more than $46 million .

Today's comprehensive global response focuses on emergency food assistance and hunger relief programs, mental health support and health worker grants, organization operational support, and in-kind personal protective equipment (PPE) donations in underserved communities and those disproportionately impacted by the pandemic such as Black, Indigenous, and People of Color (BIPOC) communities.

The PPE donation includes more than 400,000 N95 surgical masks and 430,000 KN95 respirators, all of which will be distributed by International Medical Corps. The masks will go to hospitals and health facilities chosen for their locations in COVID-19 hot spots, or directly to individuals as part of prevention efforts. In addition, these facilities serve underserved and underinsured communities, most at-risk and most affected by the pandemic.

"As the global pandemic continues to surge, our Mission compels us to help ensure our courageous frontline healthcare workers have adequate protection," said Noel Colón, Medtronic senior vice president and chief quality officer. "We are proud to equip frontline health workers delivering critical care to those in need, as well as those most at-risk and most affected by the pandemic."

Among the nonprofit organizations receiving added support from the Medtronic Foundation through its $1.6 million grant package are those focusing on rapid access to low income communities such as the COVID-19 Action Fund for Africa , Americares, Direct Relief, Meals on Wheels, and numerous food banks.

"As the coronavirus pandemic surges around the world and in our own backyard, healthcare, food assistance, and mental health pressures are at all-time highs; it is crucial for us to deliver support quickly to counteract the disproportionate effect the virus has on underserved, marginalized communities," said Paurvi Bhatt , president of the Medtronic Foundation. "In this season of giving, we are also turning our gratitude into action by coming together with our partners to support these issues and the brave frontline health workers who are in need of services themselves."

Engaging Together
In addition to the financial contributions, the Medtronic Foundation also will continue to match Medtronic employee and retiree donations to approved nonprofit organizations worldwide including those that focus on food assistance, mental health support and healthcare worker protections.

About Medtronic Foundation
Medtronic plc is the sole funder of the Medtronic Foundation, whose focus is on improving health for underserved populations worldwide, as well as supporting communities in which Medtronic employees live and give. For more information, please visit medtronicfoundation.org .

About Medtronic
Medtronic plc ( www.medtronic.com ), headquartered in Dublin, Ireland , is among the world's largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contact:



Elizabeth Costello

Erika Winkels

Medtronic Foundation

Medtronic

Public Relations

Public Relations

+1-612-940-7693

+1-763-526-8478


Ryan Weispfenning

Medtronic

Investor Relations

+1-763-505-4626

Medtronic plc (PRNewsfoto/Medtronic plc)

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/medtronic-and-the-medtronic-foundation-expand-covid-19-support-to-more-than-46-million-usd-301181760.html

SOURCE Medtronic plc

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference

Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Conference on Thursday, May 29, 2025 .

Geoff Martha , Medtronic chairman and chief executive officer, will make a formal presentation beginning at 11:00 a.m. EDT ( 10:00 a.m. CDT ). Immediately following the presentation, Martha will be joined by Thierry Piéton, Medtronic executive vice president and chief financial officer, to answer questions about the company.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase

Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase

Building momentum in key franchises including Pulsed Field Ablation, TAVR, Cardiac Rhythm Management, Diabetes, Spine, and Neuromodulation

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2025 (FY25), which ended April 25, 2025 .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
Medtronic announces intent to separate Diabetes business

Medtronic announces intent to separate Diabetes business

Enables intense focus on highest margin growth drivers where Medtronic has leading core competencies

Leading, scaled, direct-to-consumer Diabetes business poised to become standalone company; only company with a complete ecosystem to address intensive insulin management

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones

Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones

  • FDA Breakthrough Device Designation Awarded to AVIM Therapy
  • FDA IDE Approved for Virtue SAB U.S. Pivotal Trial for Launch

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, "Orchestra BioMed" or the "Company"), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced financial results for the first quarter ended March 31, 2025, and provided a business update highlighting continued regulatory momentum, disciplined operational execution, and a strengthening clinical development pipeline.

Q1 2025 Highlights:

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025

Medtronic to announce financial results for its fourth quarter and full fiscal year 2025

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2025 on Wednesday, May 21, 2025 . A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https:news.medtronic.com . The news release will include summary financial information for the company's fourth quarter and full fiscal year 2025, which ended on Friday, April 25, 2025 .

Medtronic will host a video webcast at 7:00 a.m. CDT on May 21, 2025 , to discuss results for its fourth quarter and full fiscal year 2025. The webcast can be accessed at https://investorrelations.medtronic.com .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women

New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women

Star Jones , award winning television personality & women's heart health advocate,   helps kick off heart health conversations this Mother's Day with the Medtronic 'Letter to My Mother' campaign

A new Medtronic-sponsored survey of women ages 30-50 reveals a significant gap in awareness and discussion around heart health among women and their mother-figures. Despite cardiovascular disease being the #1 killer of women in the U.S. many women are still unaware of the risk and the importance of heart health.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×